NewsRamp Science, Exploration and Discovery Podcast

Greenland Energy advances oil potential, Calidi Biotherapeutics explores inhibiting cancer RNA removal, and companies like Wheaton Precious Metals Corp. and Kraig Biocraft Laboratories achieve significant milestones.

Kraig Biocraft sets silk production record, Delta Gold funds quantum research, ESGold progresses mining project in Québec, and Planet Ventures targets space economy infrastructure.

Kraig Biocraft Laboratories breaks the record for producing spider silk, Delta Gold Technologies funds quantum research, ESGold Corp. progresses with gold-silver project, and Planet Ventures Inc. invests in space economy.

Companies like Canary Gold Corp., Oncotelic Therapeutics, and Heidelberg Pharma AG announce advancements in mining operations, cancer research, and medical technology, while researchers at MIT uncover obstacles in solid-state battery development.

University of Calgary explores vitamin B3 for glioblastoma, NanoViricides seeks measles treatment approval, and mining companies report progress in gold production and exploration efforts.

University research on vitamin B3 for glioblastoma, potential measles treatment, gold production progress, and promising cancer therapy data. Also, updates on Alaska projects and solid-state batteries.

OMRON Healthcare partners with UCSF in a remote study to detect atrial fibrillation in hypertension patients through home blood pressure monitoring, aiming to reduce stroke and heart failure risks.

Soligenix's HyBryte shows promise for CTCL treatment, Biotech Labz Supply Inc. excels as a research peptide supplier, Mordor Intelligence predicts significant growth in cancer immunotherapy market, and Lantern Pharma to showcase withZeta.ai platform for rare cancer drug discovery.

Soligenix's HyBryte shows promise in treating cutaneous T-cell lymphoma, while the cancer immunotherapy market is expected to soar by 2031, driven by companies like Calidi Biotherapeutics Inc. Lantern Pharma to present AI platform for rare cancer drug discovery.

Soligenix's HyBryte shows promising results in treating cutaneous T-cell lymphoma, MAX Power progresses in Natural Hydrogen exploration, CIRM celebrates FDA approval of KRESLADI™, and GeoVax's MVA-X platform offers durable protection with a single-dose mpox vaccine.

Soligenix progresses Phase 3 CTCL trial, LIXTE develops cancer treatment, and industry sees advancements in drug manufacturing and clinical studies.

American Heart Association and Additional Ventures lead a $20M effort to improve care for individuals with Fontan circulation, focusing on prediction, prevention, and treatment of health complications through collaboration among clinicians, researchers, and patients.

LaFleur Minerals reports positive PEA results for the Swanson Gold Project, Aptevo's mipletamig shows strong potential in AML treatment, a breakthrough in cancer immunotherapy, and Canamera Energy Metals expands rare earth footprint in Brazil.

Lahontan Gold Corp. advances Nevada assets, Canamera Energy Metals targets rare earth elements, Soligenix receives EU orphan drug designation, Powermax Minerals identifies REE targets, and D-Wave Quantum Inc. set to launch 'Quantum Matters' podcast.

Stonegate Capital Partners reports on Heliostar Metals' progress on the Ana Paula project, Lexaria Bioscience's new patents for diabetes treatment, and Okogen Inc.'s acquisition of ranpirnase assets for ophthalmic and antiviral indications.

A study in The Lancet reveals high survival rates for oropharyngeal cancer patients with proton therapy, impacting treatment trends. BioUtah showcases biotech contributions at a symposium in Washington, D.C. Meanwhile, tungsten prices soar as demand rises amidst global tensions.

Canamera Energy Metals Corp. starts a drill program in Brazil, VolitionRx reports high cancer detection rates, GeoVax completes vaccine testing, Trailbreaker Resources closes financing, AI data leakage study reveals no issues, heart disease risk in children born to mothers with placental abruption, and Golden Cariboo Resources completes a significant drill hole.

Soligenix presents promising data for HyBryte(TM) in CTCL treatment; CMX Gold & Silver Corp. and Ucore Rare Metals Inc. announce strategic initiatives; American Fusion Inc. engages in global energy research events.

Canary Gold Corp. finds potential gold-bearing system in Brazil; Trinity College Dublin researchers discover blood-brain barrier disruption supporting CardioDialysis for neuroinflammatory diseases. Andina Copper Corporation reports promising drill results at Cobrasco Project in Colombia.

BRAIN Biotech patents CRISPR nuclease, Viromed secures funding for plasma technology, Soligenix advances orphan drug, LIXTE focuses on oncology, and MAX Power Mining closes a private placement.

Angkor Resources mentors Khmer geoscientists, Noble Minerals plans Electromagnetic Survey in Timmins, and Fitzroy Minerals reports significant copper mineralization at Buen Retiro project in Chile.

Sleep and exercise can prevent Type 2 diabetes in teens; maintaining optimal blood pressure in young adulthood is crucial for heart and kidney health. Oncolytic Virus Therapy shows promise in cancer treatment, and LIXTE Biotechnology is advancing cancer treatment strategies. LaFleur Minerals is hosting a webinar to discuss recent developments and its gold mill restart.

Fitzroy Minerals Inc. reports positive drilling results at Buen Retiro, prepares for maiden mineral resource estimate, and advances geophysical surveys at Caballos in Chile.

Soligenix showcases HyBryte's efficacy, VGTel links consciousness with UAP and astronomy, Nicola Mining redefines Craigmont's porphyry potential, and new research suggests activity benefits pregnant women.

Search Minerals Inc. reveals promising rare earth element grades in Labrador, while Soligenix discusses HyBryte study for CTCL and upcoming transformative milestones. Visit Soligenix's newsroom for more information.